Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1821402Generated: October 31, 2026

Potassium Carbonate → (E)-N-{4-[2-(1H-indazol-3-yl)vinyl]-3-nitrophenyl}-N-(2-methoxyethyl)-2-morpholinoethylamine

https://huagongshe.com/reaction/1821402

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPotassium CarbonateHCID 11430—
Reactant4-Fluoro-2-nitrobenzaldehydeHCID 76226—
ReactantN-(2-methoxyethyl)-2-morpholinoethylamineHCID 23116487—
ReactantHCID 178419401HCID 178419401—
SolventDimethyl SulfoxideHCID 679—
SolventWaterHCID 962—
Product(E)-N-{4-[2-(1H-indazol-3-yl)vinyl]-3-nitrophenyl}-N-(2-methoxyethyl)-2-morpholinoethylamineHCID 6900442420%

Reaction Conditions

Temperature100 °C

Reaction Steps

4-Fluoro-2-nitrobenzaldehyde (0.20 g, 1.2 mmol), N-(2-methoxyethyl)-2-morpholinoethylamine (1.2 g, 6.5 mmol) and DMSO (3.5 mL) were added and stirred at 100° C. for 3 hours. The reaction mixture was added with water and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (hexane/ethyl acetate=1/1 to ethyl acetate). In a similar manner to Example 1, the obtained 4-[N-(2-methoxyethyl)-N-(2-morpholinoethyl)amino]-2-nitrobenzaldehyde was dissolved in methanol (8.0 mL) and the solution was added with (1H-indazol-3-ylmethyl)triphenylphosphonium bromide (0.21 g, 0.62 mmol) and potassium carbonate (0.17 g, 1.3 mmol) followed by stirring at room temperature for 1 hour. The reaction mixture was added with water and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography (chloroform to chloroform/methanol=9/1) to obtain (E)-N-{4-[2-(1H-indazol-3-yl)vinyl]-3-nitrophenyl}-N-(2-methoxyethyl)-2-morpholinoethylamine (45 mg, 20%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07605272B2
Source datasetuspto-grants-2009_10
ORD IDord-d05a919d3150479290522ecee62199de
Source noteuspto-grants-2009_10